Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11726683 | 0.66 | TSHR (0.49) | TSHRKEAP1NFE2L2HCAR2MEN1 | |
| SCHEMBL28857840 | 0.65 | HCAR2 (0.36) | TSHRKEAP1NFE2L2HCAR2MEN1 | |
| SCHEMBL518574 | 0.62 | — | — | |
| SCHEMBL23087147 | 0.62 | HCAR2 (0.46) | TSHRKEAP1NFE2L2HCAR2MEN1 | |
| SCHEMBL23087148 | 0.62 | HCAR2 (0.46) | TSHRKEAP1NFE2L2HCAR2MEN1 | |
| SCHEMBL4954055 | 0.60 | TSHR (0.44) | TSHRKEAP1NFE2L2HCAR2 | |
| SCHEMBL4954046 | 0.60 | TSHR (0.44) | TSHRKEAP1NFE2L2HCAR2 | |
| SCHEMBL9612293 | 0.60 | TSHR (0.44) | TSHRKEAP1NFE2L2HCAR2 | |
| SCHEMBL1035256 | 0.60 | TSHR (0.43) | TSHRKEAP1NFE2L2HCAR2MEN1 | |
| SCHEMBL8190673 | 0.59 | TSHR (0.42) | TSHRKEAP1NFE2L2HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5541327-A | Preparation of camptothecin analogs | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-07-30 | — | — | US | disclosed |
| US-5525731-A | CYCLIZATION; HALOGENATION; ALKYLATION; REDUCTION; HYDROLYSIS; DECARBOXYLATION; SELENYLATION | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-06-11 | — | — | US | disclosed |
| US-5446047-A | Anticancer agents | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-08-29 | — | — | US | disclosed |
| US-5391745-A | Cytotoxic activity towards cancer cells | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-02-21 | — | — | US | disclosed |